27 results
8-K
EX-10.1
KPRX
Kiora Pharmaceuticals Inc
31 Jan 24
Entry into a Material Definitive Agreement
5:14pm
will establish a joint steering committee to oversee Development, Manufacturing, Regulatory Filings and Commercialization of the Licensed Product as well
8-K
EX-99.1
KPRX
Kiora Pharmaceuticals Inc
16 Sep 22
Kiora Pharmaceuticals Appoints Melissa Tosca as Executive Vice President of Finance
4:30pm
. Mrs. Tosca will join the executive management team and oversee finance, SEC reporting and accounting functions as well as play a role in the company's
PRE 14A
59yj8 amnw2
17 May 18
Preliminary proxy
5:21pm
8-K
EX-10.1
4d3pr9ljxee6oij
10 Jul 15
EyeGate Signs Licensing Agreement with Valeant Pharmaceuticals for EGP-437 Combination Product in Uveitis
12:00am